Nuclear localization of endothelin-converting enzyme-1 - Subisoform specificity

被引:23
|
作者
Jafri, F
Ergul, A [1 ]
机构
[1] Med Coll Georgia, Vasc Biol Ctr, Clin Pharm CJ1020, Augusta, GA 30912 USA
[2] Univ Georgia, Clin & Expt Therapeut Program, Augusta, GA USA
关键词
endothelin; subcellular localization; high glucose;
D O I
10.1161/01.ATV.0000099787.21778.55
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective - The biosynthesis of endothelin-1 (ET-1), the most potent vasoconstrictor with mitogenic properties, involves the processing of intermediate protein big ET-1 by a unique metalloprotease, endothelin-converting enzyme-1 (ECE-1). ECE-1 has 4 subisoforms that possess the same catalytic properties but different localization patterns on the plasma membrane and cytosol. We investigated the trafficking of ECE-1 subisoforms using green fluorescent protein - tagged recombinant enzymes in target and nontarget cells. Methods and Results - ECE-1 localization was studied using confocal microscopy, which provides evidence for the first time that both ET-1 and ECE-1a are also found in the nuclear compartment in transiently transfected cells as well as in native endothelial cells that endogenously possess the ET system. In cells maintained in high-glucose medium, ECE-1a - specific staining shifted from plasma membrane to intracellular compartments. ECE-1b subisoform, however, is mainly in the cytosolic compartment, indicating a subisoform specificity for nuclear localization. Conclusions - Our findings define a novel localization pattern for the ET system, which may be differentially regulated under pathophysiological conditions.
引用
收藏
页码:2192 / 2196
页数:5
相关论文
共 50 条
  • [41] The influence of dietary salt intake on the expression of endothelin-converting enzyme-1 in the kidney
    Fatel, I
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2003, 5 (08): : 594 - 594
  • [42] Function and expression of endothelin-converting enzyme-1 in human vascular smooth muscle
    Ruschitzka, F
    Noll, G
    Lachat, M
    Shaw, S
    Lüscher, TF
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) : 23A - 24A
  • [43] Development of an internally quenched fluorescent substrate selective for endothelin-converting enzyme-1
    Johnson, GD
    Ahn, K
    ANALYTICAL BIOCHEMISTRY, 2000, 286 (01) : 112 - 118
  • [44] Localization and regulation of the isoforms of brain endothelin converting enzyme-1
    Barnes, K
    Walkden, BJ
    Kime, L
    Turner, AJ
    JOURNAL OF NEUROCHEMISTRY, 1998, 71 : S43 - S43
  • [45] Expression of endothelin-1 and endothelin-converting enzyme-1 mRNAs and proteins in failing human hearts
    Fukuchi, M
    Giaid, A
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 31 : S421 - S423
  • [46] Endothelin-1 inhibits endothelin-converting enzyme-1 expression in cultured rat endothelial cells
    Naomi, S
    Iwaoka, T
    Disashi, T
    Inoue, J
    Kanesaka, Y
    Tokunaga, H
    Tomita, K
    JOURNAL OF HYPERTENSION, 1998, 16 : S74 - S74
  • [47] Co-expression of endothelin-1 and endothelin-converting enzyme-1 in patients with chronic rhinitis
    Furukawa, K
    Saleh, D
    Bayan, F
    Emoto, N
    Kaw, S
    Yanagisawa, M
    Giaid, A
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1996, 14 (03) : 248 - 253
  • [48] Distinct cellular localization and regulation of endothelin-1 and endothelin-converting enzyme-1 expression in the bovine corpus luteum: Implications for luteolysis
    Levy, N
    Gordin, M
    Mamluk, R
    Yanagisawa, M
    Smith, MF
    Hampton, JH
    Meidan, R
    ENDOCRINOLOGY, 2001, 142 (12) : 5254 - 5260
  • [49] Increased expression of endothelin-converting enzyme-1α isoform in response to high glucose concentrations
    Keynan, S
    Dahan, R
    Wexler, ID
    Barnes, K
    Brown, CD
    Turner, AJ
    Raz, I
    DIABETES, 2000, 49 : A141 - A142
  • [50] Inhibitor potencies and substrate preference for endothelin-converting enzyme-1 are dramatically affected by pH
    Fahnoe, DC
    Knapp, J
    Johnson, GD
    Ahn, K
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 36 : S22 - S25